CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
Clinical trial NCT03731169 · COMPLETED
Trial details
- NCT number
- NCT03731169
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-10
- Primary completion
- 2019-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.